NCT03205137

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy Based on Database Data in Real-world Japanese Therapeutic Practice

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	subjects treated with telmisartan/hydrochlorothiazide	subjects treated with telmisartan/hydrochlorothiazide
DRUG	Subjects treated with Telmisartan and amlodipine	Subjects treated with Telmisartan and amlodipine
DRUG	subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group	subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group
DRUG	subjects treated with telmisartan+amlodipine double pill	subjects treated with telmisartan+amlodipine double pill

Timeline

• Start date: 2022-06-01
• Primary completion: 2022-07-11
• Completion: 2022-07-11
• First posted: 2017-07-02
• Last updated: 2022-06-28

Locations

1 site across 1 country: Japan